Singapore IPO

Resources Why Female-Led Private Practices Thrive in Singapore By Medinex Team May 28, 2026 By Medinex Team Do you know that female students accounted for at least 55% of the freshman cohort at NUS Yong Loo Lin School of Medicine and 53% at Duke-NUS Medical School in 2018?1 Within Singapore’s major public healthcare clusters, women now represent a powerful core of the clinician workforce: roughly 48% at SingHealth, 42% at the National Healthcare Group (NHG), and 39.1% at the National University Health System (NUHS).1 With so many more female clinicians present today, we thought it would be insightful to investigate whether women-led private practices have a clinical and business edge over their counterparts in Singapore. 1. The Competitive Advantage Of Women-Led Practices Singapore’s healthcare ecosystem is undergoing a massive paradigm shift with the nationwide rollout of the Healthier SG initiative. The medical landscape has placed an unprecedented premium on preventive medicine, long-term patient-provider trust, and localised community care. Driven by evolving patient demographics and a cultural shift towards holistic wellness, female clinicians seem to be uniquely positioned to excel. Capturing the Decision Maker In Singaporean households, women traditionally assume the role of the default caregiver—managing the healthcare, appointments, and chronic disease management for both their children and ageing parents. Female-led practices typically come across as being more relatable or empathetic. A female clinician running a private practice understands the dual-burden pressures of managing multi-generational healthcare, and this connection often leads to higher trust, resulting in the medical patronage of the entire household, exponentially lowering patient acquisition costs (CAC). Mastery of Relational Care Global and regional data consistently indicate that female healthcare providers are heavily favoured for their empathy and communication (Kitole, 2025). In private practice, this trait translates to patient retention and financial sustainability. Female clinicians excel in collaborative consultation styles and shared decision-making. This approach empowers patients and directly correlates to significantly higher patient satisfaction (Kitole, 2025) and Word-of-Mouth Referrals. High-Value Specialised Niche Cultural nuances in Asian societies mean that substantial portions of the population prefer female doctors for intimate, sensitive, or specialised care (Kitole, 2025). Specialised Practice Area Consumer Demand Obstetrics & Gynaecology (OBGYN) High demand for female practitioners driven by personal comfort and cultural preference during intimate screenings. Aesthetics & Dermatology High-margin private sectors where female clinicians leverage shared aesthetic perspectives and lifestyle relatability. Paediatrics & Family Medicine Parents frequently seek out maternal communication styles to manage childhood developmental milestones and behavioural health. 2. Ready To Launch A Women-Led Private Practice If you are a female clinician and have been thinking of starting your own private practice, here are 4 simple key considerations to guide you along. 1. Niche Positioning Leverage the high demand for specialised, empathetic care by capturing dedicated patient demographics (e.g., women-centric preventative health, specialised oncology, paediatric sub-specialities, or lifestyle-driven aesthetics). 2. Clinic Environment Design Turn patient-centred care into physical design. Craft warm, communicative, and transparent practice workflows that standouts from sterile, high-throughput corporate clinics. 3. Technology & Regulatory Compliance Plan for robust digital foundations, integrating secure EMR systems ready for the Health Information Bill (HIB) and National Electronic Health Record (NEHR) frameworks. 4. Financial & Panel Strategy Navigate corporate insurance panel entry strategically while building a strong self-paying patient base through differentiated service delivery and a good reputation. If you need further consultation on how to incorporate your private practice, send us an email at contact@medinex.com.sg. MEDINEX Limited is an established one-stop consultancy service with more than 20 years of experience in company incorporation, accounting & tax services, HR and business consultancy specialising in helping healthcare service providers. We understand the challenges and have the necessary expertise to provide the right solutions to overcome them. Tags: Women-Led Practice Female Doctors Private Practice Healthcare Business Patient Trust Healthier SG Clinic Growth Medical Entrepreneurship Women in Healthcare Clinic Management Footnote: 1. Source: https://www.sma.org.sg/news/2020/February/holding-up-half-the-sky-women-in-singapore-medicine References Berlin, G., Lapointe, M., & Murphy, M. (2018). Women in the healthcare industry. McKinsey & Company.Karakcheyeva, V. (2024). The well-being of women in healthcare professions: A comprehensive review. ResearchGate.Kitole, F. A. (2025). Exploring the gender preferences for healthcare providers and their influence on patient satisfaction. PMC, Article PMC12071379.

Resources IPO Listing in Singapore: A SME Roadmap By Medinex Team April 26, 2026 By Medinex Team The Singapore IPO market has entered a “renaissance phase” since 2025—which saw 13 listings raise over S$2.5 billion— following a suite of reforms by the Singapore Stock Exchange (SGX) and the Monetary Authority of Singapore (MAS) to revitalise the local equity market.1 For Small and Medium Enterprises (SMEs) in healthcare sectors, these changes have significantly lowered barriers to entry and support for companies after they go public. These include: Direct Financial Incentives & Tax Breaks: 20% Corporate Income Tax Rebate for 5 years.1 Structuring & Regulatory Easing: Mainboard profit threshold lowered to S$10 million.1 Boosting Market Liquidity: S$5 billion Equity Market Development Programme (EQDP).1 Post-Listing Support: S$30 million “Value Unlock” Package.2 1. 5 Benefits of IPO Listing There are many tangible benefits to IPO listing as it serves as the springboard to propel smaller businesses in healthcare onto a larger playing field in both scale of operation as well as markets they serve. Here’s a summary of these considerations. Access to vast capital for growth The most immediate and important advantage is access to vast amounts of capital from the public markets. Unlike a bank loan, this capital doesn’t require monthly interest payments and provides the funding for expansion plans that were previously out of reach. Enhanced reputation & visibility Being listed on a major exchange is a seal of approval, signaling to customers, vendors, and the general public that the company has met rigorous regulatory and financial standards. Attracting & retaining talent The branding of a publicly listed entity makes it easier for the company to recruit and retain the “best and brightest”. Lower cost of capital Public companies oAten enjoy a lower cost of capital for future financing because they are considered more transparent, as their shares are liquid, and they are oAten viewed as less risky by lenders. This allows the firm to negotiate better interest rates on debt. Creating a stronger network of business collaborators Beyond just prestige, having a public valuation makes it significantly easier to engage in Mergers and Acquisitions (M&A). Using stock as a form of payment allows for strategic partnerships and acquisitions that can solidify a company’s position within its ecosystem. 2. 6 Practical Steps For A Successful IPO Journey Using ABC IPO Listing is a major step for any company, and it is important to engage consultants who can provide professional advice with practical experience across every step of the IPO journey. Medinex Limited is a one-stop consultancy with more than 20 years of experience helping healthcare service providers through our incorporation, accounting & tax services, HR and business consultancy. The following IPO roadmap is based on our professional experience, and it provides a glimpse into the IPO journey. Do speak to us if you require further professional insights. STEP 1: A ssess Readliness The “Golden Rule” for listing remains the three-year financial audit. Investors in 2026 are highly selective, favouring companies that demonstrate “quality growth” over “growth at all costs, meaning companies that adopt a sustainable growth mindset. STEP 2: B e clear of the strategic intent STEP 2: Be clear of the strategic intent Your company stakeholders (owners, directors, management) are clear on their objectives for IPO listing, whether it is for regional expansion, strategic investment for growth, future acquisitions, and others. Alignment among stakeholders on these goals provides a strong foundation and an important starting point for the IPO journey. STEP 3: C hoose between Mainboard or Catalist STEP 3: Choose between Mainboard or Catalist Your company stakeholders (owners, directors, management) are clear on their objectives for IPO listing, whether it is for regional expansion, strategic investment for growth, future acquisitions, and others. Alignment among stakeholders on these goals provides a strong foundation and an important starting point for the IPO journey. Comparison Table Feature Mainboard Catalist Target Company Established, profitableHigh-growth, SME High-growth, SME Financial Criteria Yes: S$10m+ pre-tax profit (latest year) OR S$150m+ Mkt Cap No minimum profit/track record Sponsor Requirement No (Issue Manager only) Yes (Mandatory Full Sponsor) Prospectus Filing Lodged with MAS Offer Document via Sponsor Approval Body MAS and SGX Sponsor and SGX Visibility/Investor Institutional (organisations such as pensions, hedge funds) & Retail (Individuals) Growth-focused / Retail (Individuals) STEP 4: D etermine the Platform costs STEP 4: Determine the Platform costs Many view IPO as being prohibitively expensive, but when grants are factored in, the costs are a lot more manageable than expected. Based on our estimation, the costs for a Catalist listing typically range between S$1.5 million and S$2.5 million, covering issue managers, legal fees, and auditing. However, the MAS-backed GEMS scheme (extended to 2028) co-funds up to 20% of listing expenses, capped at S$300,000.5 STEP 5: E xecute the Restructuring Roadmap STEP 5: Execute the Restructuring Roadmap Consolidation of Ownership (Legal and asset consolidation to form a single, clean vehicle for the IPO.) Professionalising governance (Appointment and training of two Independent Directors to ensure they understand their fiduciary duties under the new SGX RegCo rules.) Tax & Legal “Housekeeping” (IRAS compliance, Audit Readiness, Asset Segregation) STEP 6: F orm the Team Last but not least, you need to assemble the team of professionals to help you with the IPO Listing, which includes sponsors (if you are listing on catalist), legal advisors, auditors, bankers, etc. Our IPO consultants can guide you through the entire journey. Footnote: 1. Source: https://www.mas.gov.sg/news/media-releases/2025/a-comprehensive-set-of-measures-to-strengthen-singapores-equities-market 2. Source: https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review 3. Source: https://sbr.com.sg/markets-investing/exclusive/sgx-reforms-set-stage-20-ipos-in-2026 4. Source: https://datatracks.com/sg/blog/sgx-ipo-readiness-2026-cfo-compliance/ 5. Source: https://www.aeilegal.com/tldr/singapore-ipos-financial-support-for-listing-on-the-singapore-exchange   MEDINEX Limited is an established one-stop consultancy service with more than 20 years of experience in company incorporation, accounting & tax services, HR and business consultancy specialising in helping healthcare service providers. We understand the challenges and have the necessary expertise to provide the right solutions to overcome them. For further consultation, send us an email at contact@medinex.com.sg. Tags: IPO Listing Singapore IPO Healthcare SME SGX Mainboard SGX Catalist IPO Readiness Business Growth Healthcare Business Advisory Corporate Governance Listing Roadmap